Aytu BioPharma (NASDAQ: AYTU) is a dynamic specialty pharmaceutical company with a growing commercial portfolio of prescription medicines addressing complex conditions, with a focus on ADHD and other common conditions. Our evolution has been driven by strategic in-licensing, acquisition-based transactions and organic product growth. As we continue on this trajectory, we continue to evaluate novel therapeutics to in-license or acquire.
View Top Employees from Aytu BioPharma| Website | https://aytubio.com |
| Ticker | AYTU |
| Revenue | $27 million |
| Funding | $5.2 million |
| Employees | 131 (131 on RocketReach) |
| Founded | 2015 |
| Address | 7900 E Union Ave 920, Denver, Colorado 80219, US |
| Phone | (720) 437-6580 |
| Technologies |
JavaScript,
HTML,
PHP
+25 more
(view full list)
|
| Industry | Pharmaceuticals, Pharmaceutical Manufacturing, Biotechnology, Men's Health, Healthcare, Science and Engineering, Health Care, Diagnostics, Medical, Urological Conditions hypogonadism, infertility, and urological |
| Web Rank | 14 Million |
| Keywords | Specialty Pharmaceutical |
| Competitors | AcelRx Pharmaceuticals, Anesiva, Flexion Therapeutics, Heron Therapeutics, Inc., Supernus Pharmaceuticals, Inc. |
| SIC | SIC Code 82 Companies, SIC Code 62 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 52 Companies, NAICS Code 3254 Companies, NAICS Code 52399 Companies, NAICS Code 523 Companies, NAICS Code 325 Companies, NAICS Code 5239 Companies, NAICS Code 523999 Companies |
Looking for a particular Aytu BioPharma employee's phone or email?
Aytu BioPharma Questions
The Aytu BioPharma annual revenue was $27 million in 2024.
Mark Oki is the CFO of Aytu BioPharma.
131 people are employed at Aytu BioPharma.
Aytu BioPharma is based in Denver, Colorado.
The NAICS codes for Aytu BioPharma are [32, 52, 3254, 52399, 523, 325, 5239, 523999].
The SIC codes for Aytu BioPharma are [82, 62].
Top Aytu BioPharma Employees
-
5+5+
-
22
-
21
-
35+
-
22
-
25+
-
35+
Related Companies
